Summary & Overview
CPT 4037F: Influenza Vaccination for Patients with Inflammatory Bowel Disease
CPT code 4037F identifies ordering or administration of an influenza vaccine for patients undergoing treatment for inflammatory bowel disease (IBD). This code captures targeted preventive immunization in an at-risk population where influenza can lead to severe, potentially life-threatening complications. Nationally, accurate capture of such vaccination events supports patient safety, quality measurement, and immunization coverage tracking for immunocompromised patient groups.
Key payers relevant to this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, coding purpose, and expected sites of service. The publication summarizes common billing practices, payer coverage considerations, and related documentation needs. It also highlights benchmarks and policy updates affecting influenza vaccination measurement for patients with chronic immunomodulating conditions. Clinical context explains why vaccination is prioritized for patients receiving IBD therapy and how CPT code 4037F is used to reflect that preventive service in claims and quality reporting.
Data not available in the input: associated taxonomies, ICD-10 diagnoses, related codes, and service line specifics beyond the provided description.
Billing Code Overview
CPT code 4037F documents that the provider orders or administers an influenza vaccination for a patient receiving treatment for inflammatory bowel disease (IBD). The code emphasizes vaccination to reduce the risk of life-threatening complications from influenza in this immunologically vulnerable population.
Service Type
- Preventive immunization aimed at influenza protection for patients undergoing treatment for inflammatory bowel disease.
Typical Site of Service
- Outpatient clinic, infusion center, or other ambulatory care settings where patients with inflammatory bowel disease receive treatment and preventive care, including vaccination during routine visits or therapy sessions.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with established moderate-to-severe inflammatory bowel disease (for example, Crohn disease) presents to a gastroenterology clinic during influenza season for ongoing biologic therapy. The patient is receiving maintenance infusions every 8 weeks and is immunomodulated with a tumor necrosis factor inhibitor. The gastroenterology nurse reviews vaccination history, documents absence of current-year influenza vaccination, verifies no contraindications (e.g., severe egg allergy or prior severe vaccine reaction), and the provider orders and administers an inactivated influenza vaccine during the clinic visit to reduce the risk of life-threatening influenza complications related to immunosuppression.
The clinical workflow includes pre-visit medication and allergy review, verification of vaccine availability and consent, documentation of vaccine lot number and site of administration in the medical record and immunization registry, application of appropriate billing modifier(s), and counseling the patient on expected adverse events and when to seek care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Used when no special circumstances or modifier-specific conditions apply to the billed vaccine administration. |
2P |